Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors - a single center experience . Clinics [Internet]. 2015 Aug. 1 [cited 2024 May 13];70(8):550-5. Available from: https://www.revistas.usp.br/clinics/article/view/102011